Tau-targeted drug discovery as a potential treatment of Alzheimer’s disease

Item Number: 625
Industry: Therapeutic
Category: Neuroscience / Neurology
Development Stage: Early Stage
Organisation Type: Government Institute
Country: South Korea
Patent: Korea
Business Opportunity: Out-Licensing


The present invention relates to discovery of novel tau-targeted therapeutic drug candidates for the treatment of Alzheimer’s disease (AD).

Features & Contact

Sign in and you'll be able to send enquiries about this item, view full details and save it